| 2025年年报 | 2025年三季报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医疗健康服务(元) | 7,372,613,007.61 | 5,448,000,000.00 | 3,591,952,888.53 | 7,647,000,000.00 | 3,659,290,439.73 |
| 医学诊断与医疗器械(元) | 4,320,614,671.89 | 3,033,000,000.00 | 1,954,524,243.34 | 4,323,000,000.00 | 2,069,292,269.29 |
| 制药(元) | 29,833,285,776.14 | 20,811,000,000.00 | 13,901,157,970.78 | 28,924,000,000.00 | 14,677,471,122.50 |
| 其他(元) | 135,099,292.51 | - | 66,796,746.94 | - | 56,758,899.63 |
| 营业成本(元) | |||||
| 医疗健康服务(元) | 5,845,971,770.45 | 4,385,000,000.00 | 2,877,960,974.58 | 5,910,000,000.00 | 2,771,850,304.14 |
| 医学诊断与医疗器械(元) | 2,140,528,596.08 | 1,459,000,000.00 | 919,652,221.89 | 2,158,000,000.00 | 1,027,989,156.58 |
| 制药(元) | 12,710,693,014.39 | 9,297,000,000.00 | 6,268,804,224.28 | 13,218,000,000.00 | 6,621,078,441.16 |
| 其他(元) | 102,909,811.30 | - | 57,047,673.61 | - | 42,467,637.68 |
| 毛利(元) | |||||
| 医疗健康服务(元) | 1,526,641,237.16 | 1,063,000,000.00 | 713,991,913.95 | 1,737,000,000.00 | 887,440,135.59 |
| 医学诊断与医疗器械(元) | 2,180,086,075.81 | 1,574,000,000.00 | 1,034,872,021.45 | 2,165,000,000.00 | 1,041,303,112.71 |
| 制药(元) | 17,122,592,761.75 | 11,514,000,000.00 | 7,632,353,746.50 | 15,706,000,000.00 | 8,056,392,681.34 |
| 其他(元) | 32,189,481.21 | - | 9,749,073.33 | - | 14,291,261.95 |
| 毛利率(%) | |||||
| 医疗健康服务(%) | 20.71 | 19.51 | 19.88 | 22.71 | 24.25 |
| 医学诊断与医疗器械(%) | 50.46 | 51.90 | 52.95 | 50.08 | 50.32 |
| 制药(%) | 57.39 | 55.33 | 54.90 | 54.30 | 54.89 |
| 其他(%) | 23.83 | - | 14.60 | - | 25.18 |
| 收入构成(%) | |||||
| 医疗健康服务(%) | 17.70 | 18.60 | 18.41 | 18.70 | 17.88 |
| 医学诊断与医疗器械(%) | 10.37 | 10.35 | 10.02 | 10.57 | 10.11 |
| 制药(%) | 71.61 | 71.05 | 71.24 | 70.73 | 71.73 |
| 其他(%) | 0.32 | - | 0.34 | - | 0.28 |
| 毛利构成(%) | |||||
| 医疗健康服务(%) | 7.32 | 7.51 | 7.60 | 8.86 | 8.87 |
| 医学诊断与医疗器械(%) | 10.45 | 11.12 | 11.02 | 11.04 | 10.41 |
| 制药(%) | 82.08 | 81.37 | 81.27 | 80.10 | 80.57 |
| 其他(%) | 0.15 | - | 0.10 | - | 0.14 |